Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinitis Pigmentosa 2”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07218692
What this trial is testing

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+6 more
City of Hope Medical Center 35
Large-scale testing (Phase 3)Looking for participantsNCT06581406
What this trial is testing

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Uveal Melanoma
Replimune, Inc. 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT05203939
What this trial is testing

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

Who this might be right for
Retinitis PigmentosaLeber Congenital Amaurosis
Ocugen 22
Large-scale testing (Phase 3)Ended earlyNCT05176717
What this trial is testing

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
Laboratoires Thea 5
Testing effectiveness (Phase 2)Looking for participantsNCT06627179
What this trial is testing

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Who this might be right for
Retinitis Pigmentosa (RP)Usher Syndrome Type 2Deaf Blind+4 more
Laboratoires Thea 81
Testing effectiveness (Phase 2)Looking for participantsNCT04278131
What this trial is testing

BS01 in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Bionic Sight LLC 20
Not applicableLooking for participantsNCT06982417
What this trial is testing

InsightRP2 Registry

Who this might be right for
RP2-associated Retinitis PigmentosaX-Linked Retinitis Pigmentosa (XLRP)Retinitis Pigmentosa 2
University of Göttingen 200
Not applicableStudy completedNCT01325506
What this trial is testing

Effectiveness of Open and Robotic Prostatectomy

Who this might be right for
Prostate Cancer
Beth Israel Deaconess Medical Center 677
Large-scale testing (Phase 3)Study completedNCT04966741
What this trial is testing

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency ObesityPCSK1 Deficiency Obesity+1 more
Rhythm Pharmaceuticals, Inc. 12
Not applicableStudy completedNCT03626207
What this trial is testing

Development of Visual Function Evaluation Method (2)

Who this might be right for
Retinitis Pigmentosa
Astellas Pharma Inc 8
Not applicableStudy completedNCT04525261
What this trial is testing

Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene

Who this might be right for
Leber Congenital Amaurosis 2Retinitis Pigmentosa 20
University of Campania Luigi Vanvitelli 60
Not applicableStudy completedNCT03840603
What this trial is testing

Impact on PCT+ FilmArray RP2 Plus Use in LRTI Suspicion in Emergency Department

Who this might be right for
Respiratory Tract Infections
BioMérieux 444
Not applicableLooking for participantsNCT06887348
What this trial is testing

Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Who this might be right for
MelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more
Replimune, Inc. 50
Large-scale testing (Phase 3)Study completedNCT05194124
What this trial is testing

Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway

Who this might be right for
Bardet-Biedl SyndromePOMC Deficiency
Rhythm Pharmaceuticals, Inc. 19
Testing effectiveness (Phase 2)Looking for participantsNCT07174726
What this trial is testing

Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

Who this might be right for
X-Linked Retinitis Pigmentosa (XLRP)
Beacon Therapeutics 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04850118
What this trial is testing

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Who this might be right for
X-Linked Retinitis Pigmentosa
Beacon Therapeutics 85
Not applicableActive Not RecruitingNCT03602820
What this trial is testing

Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

Who this might be right for
Inherited Retinal Dystrophy Due to RPE65 Mutations
Spark Therapeutics, Inc. 41
Testing effectiveness (Phase 2)Ended earlyNCT05733611
What this trial is testing

RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Who this might be right for
Refractory Metastatic Colorectal CancerpMMRMSS
Replimune, Inc. 5
Early research (Phase 1)Active Not RecruitingNCT04336241
What this trial is testing

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

Who this might be right for
Cancer
Replimune, Inc. 36
Not applicableStudy completedNCT00001347
What this trial is testing

Study of Usher Syndromes, Type 1 and Type 2

Who this might be right for
Retinitis Pigmentosa
National Eye Institute (NEI) 200
Load More Results